Antimicrobial evaluation of nocathiacins, a thiazole peptide class of antibiotics

Antimicrobial Agents and Chemotherapy

Volumn 48, Issue 10, 2004, Pages 3697-3701

  Pucci, Michael J ^a,b   Bronson, Joanne J ^a   Barrett, John F ^a,c   Denbleyker, Kenneth L ^a   Discotto, Linda F ^a   Fung Tomc, Joan C ^a   Ueda, Yasutsugu ^a  

^a BRISTOL MYERS SQUIBB   (United States)

^b Achillion Pharmaceuticals   (United States)

^c MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; BMS 249524; BMS 411886; BMS 461996; CLARITHROMYCIN; LEVOFLOXACIN; NOCATHIACIN I; POLYPEPTIDE ANTIBIOTIC AGENT; RIBOSOME PROTEIN; STREPTOMYCIN; THIAZOLE DERIVATIVE; TROVAFLOXACIN; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BACTEROIDES; BACTEROIDES FRAGILIS; CHLAMYDIA TRACHOMATIS; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM PERFRINGENS; CONTROLLED STUDY; DNA SEQUENCE; DOSE TIME EFFECT RELATION; DRUG POTENCY; DRUG SCREENING; EGGERTHELLA LENTA; ENTEROCOCCUS; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ESCHERICHIA COLI; HAEMOPHILUS INFLUENZAE; IN VITRO STUDY; LEGIONELLA PNEUMOPHILA; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; MORAXELLA CATARRHALIS; MYCOBACTERIUM AVIUM; MYCOBACTERIUM TUBERCULOSIS; MYCOPLASMA PNEUMONIAE; NONHUMAN; PEPTOSTREPTOCOCCUS; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS HAEMOLYTICUS; STREPTOCOCCUS PNEUMONIAE;

ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIA, ANAEROBIC; DNA MUTATIONAL ANALYSIS; KINETICS; MICROBIAL SENSITIVITY TESTS; MODELS, MOLECULAR; MYCOBACTERIUM; PEPTIDES, CYCLIC; THIAZOLES; VANCOMYCIN;

EID: 4644312840     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.48.10.3697-3701.2004     Document Type: Article

References (30)

1. Adam, D. 2002. Global antibiotic resistance in Streptococcus pneumoniae. J. Antimicrob. Chemother. 50(Suppl.):1-5.
2. Andrade, S. S., R. N. Jones, A. C. Gales, and H. S. Sader. 2003. Increasing prevalence of antimicrobial resistance among Pseudomonas aeruginosa isolates in Latin American medical centers: 5 year report of the SENTRY antimicrobial surveillance program (1997-2001). J. Antimicrob. Chemother. 52:140-141.
3. Barrett, C. T., and J. F. Barrett. 2003. Antibacterials: are the new entries enough to deal with the emerging resistance problems? Curr. Opin. Biotech. 14:1-6.
4. Cameron, D. M., J. Thompson, P. E. March, and A. E. Dahlberg. 2002. Initiation factor IF2, thiostrepton and micrococcin prevent the binding of elongation factor G to the Escherichia coli ribosome. J. Mol. Biol. 319:27-35.
5. Constantine, K. L., L. Mueller, S. Huang, S. Abid, K. S. Lam, W. Li, and J. Leet. 2002. Conformation and absolute configuration of nocathiacin I determined by NMR spectroscopy and chiral capillary electrophoresis. J. Am. Chem. Soc. 124:7284-7286.
6. Fauci, A. S. 2001. Infectious diseases: considerations for the 21st century. Clin. Infect. Dis. 32:675-685.
7. Fung-Tomc, J., B. Minassian, B. Kolek, T. Washo, E. Huczko, and D. Bonner. 2000. In vitro antibacterial spectrum of a new broad-spectrum 8-methoxy fluoroquinolone, gatifloxacin. J. Antimicrob. Chemother. 45:437-440.
8. Ginsburg, A. S., J. H. Grosset, and W. R. Bishai. 2003. Fluoroquinolones, tuberculosis, and resistance. Lancet Infect. Dis. 3:432-442.
9. Heffron, S. E., and F. Jurnak. 2000. Structure of an EF-Tu complex with a thiazolyl peptide antibiotic determined at 2.35 Å resolution: atomic basis for GE2270A inhibition of EF-Tu. Biochemistry 39:37-45.
10. Hrnciar, P., Y. Ueda, S. Huang, J. E. Leet, and J. J. Bronson. 2002. Synthesis of novel nocathiacin-class antibiotics. Condensation of glycolaldehyde with primary amides and tandem reductive amination of Amadori-rearranged 2-oxoethyl intermediates. J. Org. Chem. 67:8789-8793.
11. Kabsch, W., and C. Sander. 1983. Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features. Biopolymers 22:2577-2637.
12. Leet, J. E., W. Li, H. A. Ax, J. A Matson, S. Huang, R. Huang, J. L. Cantone, D. Drexler, R. A. Dalterio, and K. S. Lam. 2003. Nocathiacins, new thiazolyl peptide antibiotics from Nocardia sp. II. Isolation, characterization, and structural determination. J. Antibiot. 26:232-242.
13. Lentzen, G., R. Klinck, N. Matassova, F. Aboul-ela, and A. I. H. Murchie. 2003. Structural basis for contrasting activities of ribosome binding thiazole antibiotics. Chem. Biol. 10:769-778.
14. Li, W., J. E. Leet, H. A. Ax, D. R. Gustavson, D. M. Brown, L. Turner, K. Y. Brown, J. Clark, H. Yang, J. Fung-Tomc, and K. S. Lam. 2003. Nocathiacins, new thiazolyl peptide antibiotics from Nocardia sp. I. Taxonomy, fermentation and biological activities. J. Antibiot. 56:226-231.
15. McGee, A., and D. E. Low. 2003. Is resistance futile? Nat. Med. 9:390-392.
16. Naidu, B. N., W. Li, M. E. Sorenson, T. P. Connolly, J. A. Witchtowski, Y. Zhang, O. K. Kim, J. D. Matiskella, K. S. Lam, J. J. Bronson, and Y. Ueda. 2003. Organic reactions in frozen water: Michael addition of amines and thiols to the dehydroalanine side chain of nocathiacins. Tetrahedron Lett. 45:1059-1063.
17. National Committee for Clinical Laboratory Standards. 2002. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standard, 5th ed. M100-S12. National Committee for Clinical Laboratory Standards, Wayne, Pa.
18. Pestka, S., and J. W. Bodley. 1975. The thiostrepton group of antibiotics, p. 551-573. In J. W. Corcoran and F. E. Hahn (ed.), Antibiotics, volume 3: mechanism of antimicrobial and antitumor agents. Springer-Verlag, New York, N.Y.
19. Porse, B. T., E. Cundcliffe, and R. A. Garrett. 1999. The antibiotic micrococcin acts on protein L11 at the ribosomal GTPase centre. J. Mol. Biol. 287:33-45.
20. Porse, B. T., and R. A. Garrett. 1999. Ribosomal mechanics, antibiotics, and GTP hydrolysis. Cell 97:423-426.
21. Porse, B. T., I. Leviev, A. S. Mankin, and R. A. Garrett. 1998. The antibiotic thiostrepton inhibits a functional transition within protein L11 at the ribosomal GTPase centre. J. Mol. Biol. 276:391-404.
22. Regueiro-Ren, A., and Y. Ueda. 2002. Mild method for cleavage of dehydroalanine units: highly efficient conversion of nocathacin I to nocathiacin IV. J. Org. Chem. 67:8699-8702.
23. Rodina, M. V., A. Savelsbergh, N. B. Matassova, V. I. Katunin, Y. P. Semenkov, and W. Wintenneyer. 1999. Thiostrepton inhibits the turnover but not the GTPase of elongation factor G on the ribosome. Proc. Natl. Acad. Sci. USA 96:9586-9590.
24. Rosendahl, G., and S. Douthwaite. 1994. The antibiotics micrococcin and thiostrepton interact directly with 23S rRNA nucleotides 1067A and 1095A. Nucleic Acids Res. 22:357-363.
25. Sasaki, T., T. Otani, H. Matsumoto, and N. Unemi. 1998. MJ347-81F4 A & B, novel antibiotics from Amycolatopsis sp.: taxomonic characteristics, fermentation, and antimicrobial activity. J. Antibiot. 51:715-721.
26. Stella, S., N. Montanini, F. Le Monnier, P. Ferrari, L. Colombo, P. Landini, I. Cicilato, B. P. Goldstein, E. Selva, and M. Denaro. 1995. Antibiotic GE37468 A: a new inhibitor of bacterial protein synthesis. I. Isolation and characterization. J. Antibiot. 48:780-786.
27. Thompson, J., and E. Cundliffe. 1991. The binding of thiostrepton to 23S ribosomal RNA. Biochimie 73:31-35.
28. Weigel, L. M., D. B. Clewell, S. R. Gill, N. C. Clark, L. K. McDougal, S. E. Flannagan, J. F. Kolonay, J. Shetty, G. E. Kilgore, and F. C. Tenover. 2003. Genetic analysis of a high-level vancomycin-resistant isolate of Staphylococcus aureus. Science 302:1569-1571.
29. Wimberly, B. T., R. Guymon, J. P. McCutcheon, S. W. White, and V. Ramakrishman. 1999. A detailed view of a ribosomal active site: the structure of the L11-RNA complex. Cell 97:491-502.
30. Xing, Y., and D. E. Draper. 1995. Cooperative interactions of RNA and thiostrepton antibiotic with two domains of ribosomal protein L11. Biochemistry 35:1581-1588.